Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
topic_facet:"Triple Negative Breast Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Triple+Negative+Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Triple+Negative+Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Triple+Negative+Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (757)
1
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer : I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer : Multimodality Breast Imaging for the Assessment of Tumor Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies : Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors : A Phase 1/2 Open-Label Study of Sacituzumab Govitecan in Japanese Patients With Advanced Solid Tumors (ASCENT-J02)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers : A Phase I, Open-label, Multi-center Study of KFA115 as a Single Agent and in Combination With Pembrolizumab in Patients With Select Advanced Cancers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors : A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination With Other Anticancer Therapies in Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells : Study of Administration of T Cells Expressing B7-H3 Specific Chimeric Antigen Receptors and Containing the Inducible Caspase 9 Safety Switch in Subjects With Triple Negative Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer : A Phase 1/2, Multicenter, Open Label, Dose Escalation & Dose Expansion Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, Monotherapy or in Combination in Patients With Unresectable Locally Advanced or Metastatic Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer : A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial : NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[76]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Breast Neoplasms
Filter aufheben
Thema: Triple Negative Breast Neoplasms
Medienart
757
Aufsätze
757
E-Artikel
757
E-Ressourcen
Zeitschriftentitel
757
ClinicalTrials.gov
Thema
757
610
Breast Neoplasms
Triple Negative Breast Neoplasms
697
Study Type: Interventional
331
Phase: Phase 2
256
Recruitment Status: Recruiting
173
Recruitment Status: Completed
125
Phase: Phase 1
122
Recruitment Status: Active, not recruiting
84
Carcinoma
82
Phase: Phase 1, Phase 2
80
Phase: Phase 3
78
Recruitment Status: Not yet recruiting
59
Medical Condition: Breast Cancer
59
Medical Condition: Triple Negative Breast Cancer
58
Recruitment Status: Terminated
57
Study Type: Observational
56
Neoplasms
36
Recruitment Status: Withdrawn
33
Ovarian Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
643
2020-
114
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
757
Englisch
Haven't found what you're looking for?
Wird geladen...